EL
Edwards Larry Todd
See Remarks
M
内部人交易记录
其他基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Discover the complete record of transactions filed by Edwards Larry Todd, See Remarks. Director active across 2 companies, notably Arcutis Biotherapeutics, Inc.. In total, 13 filings have been logged. Split: 1 buy · 6 sells. Total volume traded: €915k. Activity tracked since 27 September 2023. The latest transaction was disclosed on 24 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Edwards Larry Todd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
100,000 股0Common StockSEC:0000907654-26-000084:0
30,000 股0Common StockSEC:0001628280-26-014328:0
2,052 股@ US$25.49844.8% 占其流量Common StockSEC:0001628280-26-005566:0
29,131 股@ US$25.159767.7% 占其流量Common StockSEC:0001994805-25-000008:0
4,207 股@ US$19.98850.0027% mcap50.0% 占其流量Common StockSEC:0001994805-25-000005:0
7,451 股@ US$14.07199.9% 占其流量Common StockSEC:0002065881-25-000009:0
38,000 股0Common StockSEC:0001787306-25-000039:0
2,173 股@ US$12.702.9% 占其流量Common StockSEC:0001787306-25-000013:0
1,093 股@ US$7.1060.8% 占其流量Common StockSEC:0001787306-24-000169:0
3,725 股@ US$10.01223.6% 占其流量Common StockSEC:0001787306-24-000136:0
60,000 股0Common StockSEC:0001787306-24-000081:0
28,000 股0Common StockSEC:0001787306-24-000010:0
60,000 股0Common StockSEC:0001787306-23-000113:0
About Edwards Larry Todd
Edwards Larry Todd has 12 filings in total, all observed in the recent sample from 2023-10-03 to 2026-03-03. The buy and sell amounts in that sample are EUR 7353 and EUR 907407, the modal transaction nature is Sale, and the filings concern Arcutis Biotherapeutics, Inc.